Trending...
- ReviewsAlly Launches Evidence-Based Review Platform for VPNs, Business Software, and Online Services
- Week 47 Final Freedom Vigil at Alligator Alcatraz: Truth Out
- Christmas Miracle Chronicles - New movie coming up this holiday season !
DENVER--(BUSINESS WIRE)--ClinOne, an industry leader in virtual clinical trial patient management, continues to expand its platform with FDA-approved wearable technology to capture 15 remote digital endpoints. Featuring continuous vital sign and behavioral monitoring, ClinOne provides real-time insight into biometric data, sleep and activity levels, and symptomatic or adverse event (AE) indicators, without adding patient burden or introducing compliance risk.
Digital endpoints captured automatically by passive wearable monitoring include:
Additionally, ClinOne collects task-based endpoints, such as blood pressure, pulse oximeter readings, and electrocardiogram results. Patients are responsible for taking these endpoints at specific times and are reminded with alerts through ClinOne's patient concierge solution to ensure timeliness and improve compliance. Endpoints are provided in near-real-time through encrypted cellular data.
More on Colorado Desk
"Objective measurement data used for endpoint analysis are too important to leave to chance," says Rob Bohacs (LinkedIn), co-founder and CEO of ClinOne. "And while patients want to provide clean data, typical compliance and accuracy are notoriously low. It is our responsibility to capture reliable data without getting in the way of patients' everyday lives. Our expanded offerings for FDA-approved wearable technology improves study conduct by providing real-world evidence you can trust, while reducing, and in many cases eliminating, the need for site visits to maintain patient safety oversight."
Through the ClinOne platform, the company allows pharmaceutical sponsors, research sites, and clinical trial participants to perform and automate key clinical trial operational tasks including clinical trial recruitment, study execution, compliance, and patient retention from any location worldwide. ClinOne's modules span patient recruitment, remote consent (eConsent), patient reported outcomes and surveys (ePRO), dosing management, and remote vital sign management data collection – all seamlessly integrated with home healthcare visits and telemedicine video visits – to advance clinical research into the post-COVID-19 era.
More on Colorado Desk
"At our core, we are passionate that technology can do so much more than digitize the flawed processes of the past. In fact, we believe it is the collective responsibility of ClinOne and other industry providers to enable new insights, new safety measures, and new levels of data analytics previously thought impossible, without adding burden to patients, sites, or study teams. Wearable technology can be a big piece of that puzzle, which is why we are so pleased and proud to expand our offering of at-home digital endpoints to improve the accuracy and effectiveness of decentralized clinical trials," says Bohacs.
To request a demo or start a conversation about how ClinOne can transform your next trial, visit www.ClinOne.com or contact Hello@ClinOne.com.
About ClinOne
The ClinOne solution and its suite of products are proven to accelerate clinical trial enrollment and remote patient care, compliance, and retention. The company's sole mission is to strengthen connectivity and management of participating researchers, patients, and caregivers on-site and remotely. ClinOne's systems are HIPAA, FDA CRF 21 Part 11, and GDPR compliant and validated, and have been used across 55 countries by more than 50 sponsors and 90,000 investigators since 2016. Learn more at www.clinone.com.
Digital endpoints captured automatically by passive wearable monitoring include:
- Biometrics: heart rate at rest, respiratory rate, skin and core body temperature
- Behavioral monitoring: body position, activity level, sleep status
- Symptomatic data: fall detection, cough and sneeze detection, AE indicators
Additionally, ClinOne collects task-based endpoints, such as blood pressure, pulse oximeter readings, and electrocardiogram results. Patients are responsible for taking these endpoints at specific times and are reminded with alerts through ClinOne's patient concierge solution to ensure timeliness and improve compliance. Endpoints are provided in near-real-time through encrypted cellular data.
More on Colorado Desk
- Decorated Vietnam Veteran Brings Rally4Vets America Grand Tour to Denver
- Bike to Work Day is tomorrow; riders can visit more than 40 breakfast stations across Colorado Springs
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Keeping Colorado Communities Safe: Governor Polis Thanks Law Enforcement and Local Partners for Major Decreases in Auto Thefts
- Boston Industrial Solutions Introduces High-Performance Primer for Bonding Liquid Silicone to Epoxy
"Objective measurement data used for endpoint analysis are too important to leave to chance," says Rob Bohacs (LinkedIn), co-founder and CEO of ClinOne. "And while patients want to provide clean data, typical compliance and accuracy are notoriously low. It is our responsibility to capture reliable data without getting in the way of patients' everyday lives. Our expanded offerings for FDA-approved wearable technology improves study conduct by providing real-world evidence you can trust, while reducing, and in many cases eliminating, the need for site visits to maintain patient safety oversight."
Through the ClinOne platform, the company allows pharmaceutical sponsors, research sites, and clinical trial participants to perform and automate key clinical trial operational tasks including clinical trial recruitment, study execution, compliance, and patient retention from any location worldwide. ClinOne's modules span patient recruitment, remote consent (eConsent), patient reported outcomes and surveys (ePRO), dosing management, and remote vital sign management data collection – all seamlessly integrated with home healthcare visits and telemedicine video visits – to advance clinical research into the post-COVID-19 era.
More on Colorado Desk
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
- Colorado: DOLA Invests $22.3 Million to Build More Housing, Strengthen Local Economies, and Improve Schoolyards and Community Gathering Spaces
- Verbica Challenges Panetta to a Televised Debate on the Issues
- Salt Lake City Families Turn to Private Autopsy Services for Faster Answers After Unexpected Loss
- K2 Integrity's U.S. and EMEA Teams Again Recognized in Chambers and Partners 2026 Guides
"At our core, we are passionate that technology can do so much more than digitize the flawed processes of the past. In fact, we believe it is the collective responsibility of ClinOne and other industry providers to enable new insights, new safety measures, and new levels of data analytics previously thought impossible, without adding burden to patients, sites, or study teams. Wearable technology can be a big piece of that puzzle, which is why we are so pleased and proud to expand our offering of at-home digital endpoints to improve the accuracy and effectiveness of decentralized clinical trials," says Bohacs.
To request a demo or start a conversation about how ClinOne can transform your next trial, visit www.ClinOne.com or contact Hello@ClinOne.com.
About ClinOne
The ClinOne solution and its suite of products are proven to accelerate clinical trial enrollment and remote patient care, compliance, and retention. The company's sole mission is to strengthen connectivity and management of participating researchers, patients, and caregivers on-site and remotely. ClinOne's systems are HIPAA, FDA CRF 21 Part 11, and GDPR compliant and validated, and have been used across 55 countries by more than 50 sponsors and 90,000 investigators since 2016. Learn more at www.clinone.com.
Filed Under: Business
0 Comments
Latest on Colorado Desk
- Governor Polis and the Colorado Department of Health Care Policy and Financing Open Applications for $160 Million to Reduce Healthcare Costs and Improve Access to Healthcare in Rural Colorado
- City announces plans to create Colorado Springs 911 Authority
- Colorado Springs: City Council leadership announces additional funding for the Pikes Peak or Bust Parade
- The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth
- Cango Mobility x Hikvision Announce Strategic Partnership
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
- Colorado Springs: Podcast: Meet the new Parks, Recreation & Cultural Services Director
- Colorado Springs: Podcast: Safety Snapshot with Chief Vasquez - Cloned
- Resource Central's Popular Garden In A Box Returns June 24 as Colorado Drought Drives Record Demand for Waterwise Landscaping
- George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
- Mister Omaha Tries The Turf At Lone Star Park
- Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
- The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence
- Ghanaian Afrobeat Artist Praise Kusi Announces Upcoming EP "After 21:00" Releasing July 3, 2026
- TURRENTINE: A Family Legacy United Through Music
- GracePoint Publishing Highlights renewed interest in metaphyscial topics